COGENT BIOSCIENCES, INC. logo

COGENT BIOSCIENCES, INC.

26 Marks
Corp.
First Filed:Sep 13, 2023Latest Filed:Aug 21, 2026Address:180 Third Avenue, 4th Floor, Waltham, MA 02451, US

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
22(85%)
Class 42
Software, IT Services & Scientific Research
5(19%)
Class 44
Medical, beauty and agricultural services
1(4%)

TTAB Proceedings

Proceedings
1
As Plaintiff
0(0%)
As Defendant
1(100%)
Extensions of Time
8

Top Firms

Loading...

Trademark Activity Timeline(2023 – 2026)

Trademark Portfolio

26 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
KITVAY (BEZUCLASTINIB) TABLETS
KITVAY (BEZUCLASTINIB) TABLETS
Trademark
Combined
PENDING
Owner:
Serial:50064193
Filed:Aug 21, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVI (BEZUCLASTINIB) TABLETS
KITVI (BEZUCLASTINIB) TABLETS
Trademark
Combined
PENDING
Owner:
Serial:50064173
Filed:Aug 21, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
COGENT CONNECT
COGENT CONNECT
Service Mark
Combined
PENDING
Owner:
Serial:50015725
Filed:Jul 27, 2026
Classes:35, 36, 41, +2
Description: Class 35: Business administration of medication reimbursement programs and services
Class 36: Financial administration of medication reimbursement programs and services; Providing insurance information in the field of health insurance and health insurance reimbursement; Administration of financial assistance and reimbursement programs, namely, administration of financial assistance and reimbursement programs that enable patients to more affordably access prescription drugs for the treatment of cancer and rare genetic diseases
Class 41: Educational services, namely, conducting patient education programs in the field of disease management
Class 44: Providing a website featuring educational information, namely, information for patients relating to cancer and rare genetic diseases and their prescribed medication; Providing a website featuring educational information regarding therapeutic properties of pharmaceutical products to patients relating to cancer and rare diseases; Providing educational information about healthcare; Healthcare services, namely, disease management programs; Prescription refill reminder services
Class 45: Providing case management services, namely, coordinating medical services and medication programs for patients with cancer and rare genetic diseases
EKITNA (BEZUCLASTINIB) TABLETS
EKITNA (BEZUCLASTINIB) TABLETS
Trademark
Combined
PENDING
Owner:
Serial:99888492
Filed:Jun 16, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITROVI (BEZUCLASTINIB) TABLETS
KITROVI (BEZUCLASTINIB) TABLETS
Trademark
Combined
PENDING
Owner:
Serial:99888486
Filed:Jun 16, 2026
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
AHKITNA
AHKITNA
Trademark
Word
PENDING
Owner:
Serial:99254034
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
AKITNA
AKITNA
Trademark
Word
PENDING
Owner:
Serial:99253974
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EKIDNA
EKIDNA
Trademark
Word
PENDING
Owner:
Serial:99254105
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EUKITNA
EUKITNA
Trademark
Word
PENDING
Owner:
Serial:99254019
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITBY
KITBY
Trademark
Word
PENDING
Owner:
Serial:99254070
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVAY
KITVAY
Trademark
Word
PENDING
Owner:
Serial:99254091
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVI
KITVI
Trademark
Word
PENDING
Owner:
Serial:99254078
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVY
KITVY
Trademark
Word
PENDING
Owner:
Serial:99254084
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
UKITNA
UKITNA
Trademark
Word
PENDING
Owner:
Serial:99253984
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
YUKITNA
YUKITNA
Trademark
Word
PENDING
Owner:
Serial:99253999
Filed:Jun 26, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EKITNA
EKITNA
Trademark
Word
PENDING
Owner:
Serial:99203845
Filed:May 27, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITVOVI
KITVOVI
Trademark
Word
PENDING
Owner:
Serial:99138158
Filed:Apr 15, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
KITELVY
KITELVY
Trademark
Word
ABANDONED
Owner:
Serial:99135823
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase
KITRELVY
KITRELVY
Trademark
Word
ABANDONED
Owner:
Serial:99135812
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase
KITROVI
KITROVI
Trademark
Word
PENDING
Owner:
Serial:99135828
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
ZUKITNA
ZUKITNA
Trademark
Word
PENDING
Owner:
Serial:99135835
Filed:Apr 14, 2025
Classes:5
Description: Pharmaceutical preparations for the treatment of systemic mastocytosis and gastrointestinal stromal tumors mediated by a c-kit or mutant c-kit protein kinase
EKIDNA
EKIDNA
Service Mark
Word
ABANDONED
Owner:
Serial:98340590
Filed:Jan 3, 2024
Classes:42
Description: Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for therapeutic use, protein-based toxins for therapeutic use, protein-based toxins generated in an in vitro cell-free expression system for therapeutic and medical research uses; Research and development in the field of bioinformatics and production of protein-based toxins having therapeutic applications; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development of new toxin compounds for therapeutic use, namely, new protein-based toxins for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for diagnostic use, protein-based toxins for diagnostic use, protein-based toxins generated in an in vitro cell-free expression system for diagnostic and medical research uses
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Service Mark
Word
PENDING
Owner:
Serial:98178242
Filed:Sep 13, 2023
Classes:42
Description: "BIOSCIENCES"; Development of pharmaceutical preparations and medicines; Scientific research and development; Pharmaceutical research and development services; Clinical research for others in the fields of oncology, rare diseases, and genetically defined diseases; Medical and scientific research, namely, conducting clinical trials for others
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Service Mark
Combined
REGISTERED
Owner:
Serial:98178287
Filed:Sep 13, 2023
Classes:42
Registration:8387388
Registered:Aug 11, 2026
Description: "BIOSCIENCES"; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Trademark
Word
REGISTERED
Owner:
Serial:98178294
Filed:Sep 13, 2023
Classes:5, 42
Registration:8387389
Registered:Aug 11, 2026
Description: Pharmaceutical preparations in the fields of oncology, rare diseases, and genetically defined diseases; "BIOSCIENCES"; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials
COGENT BIOSCIENCES
COGENT BIOSCIENCES
Trademark
Combined
PENDING
Owner:
Serial:98178274
Filed:Sep 13, 2023
Classes:5, 42
Description: Pharmaceutical preparations in the fields of oncology, rare diseases, and genetically defined diseases; "BIOSCIENCES"; Development of pharmaceutical preparations and medicines; Scientific research and development; Pharmaceutical research and development services; Clinical research for others in the fields of oncology, rare diseases, and genetically defined diseases; Medical and scientific research, namely, conducting clinical trials for others